title: Late Pulmonary Toxicity Associated With Everolimus in a Renal Transplant Patient and Review of the Literature.
abstract: The use of inhibitors of mammalian target of rapamycin is associated with adverse pulmonary effects. Although sirolimus-related pneumonitis has been well described, reports on pneumonitis with everolimus are scarce. We report a case of everolimus-induced pneumonitis in a renal transplant recipient 5 years after initiation of everolimus treatment, and we also review the literature regarding everolimus-induced pneumonitis in renal transplant patients.
authors.affiliation: From the Department of Internal Medicine, Division of Nephrology, Marmara University School of Medicine, Istanbul, Turkey.
authors.forename: Arzu
authors.initials: A
authors.lastname: Velioglu
authors.forename: Emel
authors.initials: E
authors.lastname: Eryuksel
authors.forename: Cagatay
authors.initials: C
authors.lastname: Cimsit
authors.forename: Serhan
authors.initials: S
authors.lastname: Tuglular
authors.forename: Cetin
authors.initials: C
authors.lastname: Ozener
mesh_terms: D000368:Aged; D057915:Drug Substitution; D000068338:Everolimus / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D011014:Pneumonia / Q000139:chemically induced* / Q000000981:diagnostic imaging; D016559:Tacrolimus / Q000008:administration & dosage; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D000068338:Everolimus; D016559:Tacrolimus